INHIBITORY EFFECT OF ASPIRIN ON PLATELET AND VASCULAR PROSTAGLANDINS IN RATS CANNOT BE COMPLETELY DISSOCIATED

被引:99
作者
VILLA, S
LIVIO, M
DEGAETANO, G
机构
[1] Laboratory of Cardiovascular Clinical Pharmacology, Istituto di Ricerche Farmacologiche 'Mario Negri', Milan
关键词
D O I
10.1111/j.1365-2141.1979.tb01151.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Summary. Blood platelets and vascular endothelium generate prostaglandin derivatives with opposing effects: cyclic endoperoxides and thromboxane A2 (TXA2) aggregate platelets, whereas prostaglandin I2 (PGI2, prostacyclin) inhibits aggregation. Since aspirin inhibits the synthesis and effects of all these metabolites of arachidonic acid, the rationale for clinical use of this drug in thrombosis prevention trials is questionable. Treatment schedules would have to be calibrated to inhibit proaggregating platelet prostaglandins and TXA2 without affecting protective vascular prostaglandins (PGI2). This important clinical information cannot easily be obtained from studies in man. The present study indicates that normal rat platelets are more sensitive to aspirin (ID50=3.6 mg/kg) than arterial tissues (ID50=25.0 mg/kg) and are almost as sensitive as venous tissues (ID50=2.3 mg/kg). Platelet prostaglandin production was monitored through the measurement of malondialdehyde (MDA) output under standard stimulation with thrombin. PGI2‐like activity released from the abdominal aorta and inferior vena cava was determined as platelet aggregation inhibitory potency and characterized by standard criteria. The inhibitory effect of aspirin (at doses of 10 and 50 mg/kg) on platelet MDA production lasted much longer in platelets (96–120 h) than in venous (24–72 h) or arterial tissue (less than 24 h). The findings suggest that in rats the (potentially antithrombotic) effect of aspirin on platelet prostaglandin and TXA2 generation may be distinguished, though not completely, from the (potentially prothrombotic) effect on vascular PGI2 on the basis of duration of inhibition more than on the sensitivity of the target cells to the drug. The different capacities of anucleated platelets and of nucleated vascular endothelial cells to overcome aspirin inhibition could be exploited for more rational clinical use of this drug. Copyright © 1979, Wiley Blackwell. All rights reserved
引用
收藏
页码:425 / 431
页数:7
相关论文
共 25 条
[1]   CULTURED HUMAN-SKIN FIBROBLASTS AND ARTERIAL CELLS PRODUCE A LABILE PLATELET-INHIBITORY PROSTAGLANDIN [J].
BAENZIGER, NL ;
DILLENDER, MJ ;
MAJERUS, PW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1977, 78 (01) :294-301
[2]   METABOLISM OF (C-14) ARACHIDONIC-ACID BY HUMAN PLATELETS [J].
BILLS, TK ;
SMITH, JB ;
SILVER, MJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 424 (02) :303-314
[3]   INHIBITION OF PLATELET PROSTAGLANDIN SYNTHETASE BY ORAL ASPIRIN [J].
BURCH, JW ;
STANFORD, N ;
MAJERUS, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (02) :314-319
[4]   PROSTAGLANDIN ENDOPEROXIDES - NOVEL TRANSFORMATIONS OF ARACHIDONIC-ACID IN HUMAN PLATELETS [J].
HAMBERG, M ;
SAMUELSS.B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (09) :3400-3404
[5]   THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES [J].
HAMBERG, M ;
SVENSSON, J ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) :2994-2998
[6]   DURATION OF INHIBITION OF PLATELET PROSTAGLANDIN FORMATION AND AGGREGATION BY INGESTED ASPIRIN OR INDOMETHACIN [J].
KOCSIS, JJ ;
HERNANDOVICH, J ;
SILVER, MJ ;
SMITH, JB ;
INGERMAN, C .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1973, 3 (02) :141-144
[7]   ASPIRIN AND THROMBOEMBOLISM - POSSIBLE DILEMMA [J].
MARCUS, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (23) :1284-1285
[8]  
MONCADA S, 1978, LANCET, V1, P1286
[9]   ENZYME ISOLATED FROM ARTERIES TRANSFORMS PROSTAGLANDIN ENDOPEROXIDES TO AN UNSTABLE SUBSTANCE THAT INHIBITS PLATELET-AGGREGATION [J].
MONCADA, S ;
GRYGLEWSKI, R ;
BUNTING, S ;
VANE, JR .
NATURE, 1976, 263 (5579) :663-665
[10]  
MONCADA S, 1977, LANCET, V1, P18